NO20043117L - Imidazokinolinderivater - Google Patents

Imidazokinolinderivater

Info

Publication number: NO20043117L
Authority: NO; Norway
Prior art keywords: imidazokinolinderivater
Prior art date: 2001-12-21

Application number

NO20043117A

Other languages

English (en)

Other versions

NO329743B1 (no

Inventor

Judit Szeredi

Maria Balogh

Sandor Batori

Zoltan Kapui

Endre Mikus

Lajos T Nagy

Laszlo Balazs

Geza Timari

Kinga Boer

Katalin Urban-Szabo

Peter Aranyi

Katalin Gerber

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2004-07-20

Publication date

2004-07-20

2004-07-20 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2004-07-20 Publication of NO20043117L publication Critical patent/NO20043117L/no

2010-12-13 Publication of NO329743B1 publication Critical patent/NO329743B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)

NO20043117A 2001-12-21 2004-07-20 Imidazokinolinderivater, fremgangsmate for fremstilling derav, mellomprodukter i fremgangsmaten for fremstilling av forbindelsene, farmasoytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene til fremstilling av farmasoytiske preparater NO329743B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0105406A HUP0105406A3 (en)	2001-12-21	2001-12-21	Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
PCT/HU2002/000144 WO2003053969A1 (en)	2001-12-21	2002-12-17	Imidazoquinoline derivatives

Publications (2)

Publication Number	Publication Date
NO20043117L true NO20043117L (no)	2004-07-20
NO329743B1 NO329743B1 (no)	2010-12-13

Family

ID=47711504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043117A NO329743B1 (no)	2001-12-21	2004-07-20	Imidazokinolinderivater, fremgangsmate for fremstilling derav, mellomprodukter i fremgangsmaten for fremstilling av forbindelsene, farmasoytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene til fremstilling av farmasoytiske preparater

Country Status (23)

Country	Link
US (1)	US7176213B2 (no)
EP (1)	EP1456205A1 (no)
JP (1)	JP4530663B2 (no)
KR (2)	KR20070034136A (no)
CN (1)	CN1307174C (no)
AU (1)	AU2002353241B2 (no)
BR (1)	BR0215272A (no)
CA (1)	CA2470067C (no)
EA (1)	EA007226B1 (no)
HR (1)	HRP20040671A2 (no)
HU (1)	HUP0105406A3 (no)
IL (2)	IL162443A0 (no)
IS (1)	IS7317A (no)
MA (1)	MA27240A1 (no)
MX (1)	MXPA04006115A (no)
NO (1)	NO329743B1 (no)
NZ (1)	NZ534015A (no)
PL (1)	PL370761A1 (no)
RS (1)	RS56104A (no)
TN (1)	TNSN04105A1 (no)
UA (1)	UA78745C2 (no)
WO (1)	WO2003053969A1 (no)
ZA (1)	ZA200404807B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005514330A (ja) *	2001-09-24	2005-05-19	イーランファーマスーティカルズ、インコーポレイテッド	アルツハイマー病治療のための置換アミン
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
HUP0400812A2 (en) *	2004-04-19	2006-02-28	Sanofi Aventis	Crystalline forms of 2-amino-3-cyano-quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
EP1858326A4 (en) *	2005-02-22	2008-10-15	Univ California	METHOD FOR THE TREATMENT OF STOMACH-DARM-INFLAMMATION
HUP0700395A2 (en) *	2007-06-07	2009-03-02	Sanofi Aventis	Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
US8357132B1 (en)	2009-10-21	2013-01-22	Lekweuwa Agatha N	Urine capturing assembly
MX369611B (es)	2013-02-01	2019-11-14	Wellstat Therapeutics Corp	Compuestos de amina que tienen actividad anti-inflamatoria, antifungica, antiparasitaria y anticancer.
ES2578363B1 (es)	2015-01-22	2017-01-31	Palobiofarma, S.L.	Moduladores de los receptores A3 de adenosina
PE20181366A1 (es)	2015-08-03	2018-08-27	Bristol Myers Squibb Co	Compuestos heterociclicos utiles como moduladores de factor de necrosis tumoral (tnf) alfa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4075343A (en) *	1976-09-13	1978-02-21	Pfizer Inc.	Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
GB1596652A (en) *	1977-01-20	1981-08-26	Roussel Lab Ltd	Imidazo (1,2-a) quinoline-2-carboxylic acid and derivatives
IL59104A (en) *	1979-02-09	1984-02-29	Roussel Uclaf	Heterotricyclic derivatives,process for their preparation and pharmaceutical compositions incorporating them
GR76063B (no) *	1981-04-03	1984-08-03	Roussel Uclaf
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

2001
- 2001-12-21 HU HU0105406A patent/HUP0105406A3/hu unknown
2002
- 2002-12-17 IL IL16244302A patent/IL162443A0/xx unknown
- 2002-12-17 MX MXPA04006115A patent/MXPA04006115A/es active IP Right Grant
- 2002-12-17 BR BR0215272-0A patent/BR0215272A/pt not_active IP Right Cessation
- 2002-12-17 UA UA20040706065A patent/UA78745C2/uk unknown
- 2002-12-17 EP EP02788261A patent/EP1456205A1/en not_active Withdrawn
- 2002-12-17 JP JP2003554685A patent/JP4530663B2/ja not_active Expired - Fee Related
- 2002-12-17 PL PL02370761A patent/PL370761A1/xx not_active Application Discontinuation
- 2002-12-17 KR KR1020077004953A patent/KR20070034136A/ko not_active Application Discontinuation
- 2002-12-17 CN CNB02825645XA patent/CN1307174C/zh not_active Expired - Fee Related
- 2002-12-17 AU AU2002353241A patent/AU2002353241B2/en not_active Ceased
- 2002-12-17 US US10/499,251 patent/US7176213B2/en not_active Expired - Fee Related
- 2002-12-17 CA CA2470067A patent/CA2470067C/en not_active Expired - Fee Related
- 2002-12-17 RS YU56104A patent/RS56104A/sr unknown
- 2002-12-17 KR KR1020047009788A patent/KR100725298B1/ko not_active IP Right Cessation
- 2002-12-17 WO PCT/HU2002/000144 patent/WO2003053969A1/en active Application Filing
- 2002-12-17 NZ NZ534015A patent/NZ534015A/en not_active IP Right Cessation
- 2002-12-17 EA EA200400847A patent/EA007226B1/ru not_active IP Right Cessation
2004
- 2004-06-07 MA MA27725A patent/MA27240A1/fr unknown
- 2004-06-08 TN TNP2004000105A patent/TNSN04105A1/en unknown
- 2004-06-10 IL IL162443A patent/IL162443A/en not_active IP Right Cessation
- 2004-06-16 IS IS7317A patent/IS7317A/is unknown
- 2004-06-17 ZA ZA200404807A patent/ZA200404807B/xx unknown
- 2004-07-20 HR HR20040671A patent/HRP20040671A2/xx not_active Application Discontinuation
- 2004-07-20 NO NO20043117A patent/NO329743B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA200404807B (en)	2005-08-29
US20050070566A1 (en)	2005-03-31
IS7317A (is)	2004-06-16
HUP0105406A2 (hu)	2003-10-28
KR100725298B1 (ko)	2007-06-07
AU2002353241A1 (en)	2003-07-09
EA007226B1 (ru)	2006-08-25
MA27240A1 (fr)	2005-03-01
EA200400847A1 (ru)	2004-12-30
EP1456205A1 (en)	2004-09-15
UA78745C2 (en)	2007-04-25
CA2470067A1 (en)	2003-07-03
JP4530663B2 (ja)	2010-08-25
KR20070034136A (ko)	2007-03-27
NZ534015A (en)	2005-04-29
NO329743B1 (no)	2010-12-13
CN1606555A (zh)	2005-04-13
PL370761A1 (en)	2005-05-30
RS56104A (en)	2006-10-27
US7176213B2 (en)	2007-02-13
HUP0105406A3 (en)	2003-12-29
HUP0105406D0 (en)	2002-03-28
MXPA04006115A (es)	2005-06-08
KR20040072670A (ko)	2004-08-18
IL162443A0 (en)	2005-11-20
BR0215272A (pt)	2004-12-14
CA2470067C (en)	2011-02-15
WO2003053969A1 (en)	2003-07-03
JP2005516956A (ja)	2005-06-09
AU2002353241B2 (en)	2008-07-10
HRP20040671A2 (en)	2005-08-31
TNSN04105A1 (en)	2006-06-01
CN1307174C (zh)	2007-03-28
IL162443A (en)	2010-05-17

Publication	Publication Date	Title
DE50204184D1 (de)	2005-10-13	Espressobrüheinrichtung
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50212173D1 (de)	2008-06-12	sgängern
DE50206021D1 (de)	2006-05-04	Schlauchklemme
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE50209238D1 (de)	2007-02-22	Kugelgelenk
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
DE50211604D1 (de)	2008-03-13	Chlag
DE50209410D1 (de)	2007-03-22	Kugelgelenk
DE50204551D1 (de)	2005-11-17	Kugelgelenk
DE50208372D1 (de)	2006-11-23	Schrankaufhängevorrichtung
DE50211290D1 (de)	2008-01-10	Handzange
DE50204794D1 (de)	2005-12-08	Kugelgelenk
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50208029D1 (de)	2006-10-12	Kugelgelenk
DE50201862D1 (de)	2005-01-27	Messwandler
IS7317A (is)	2004-06-16	Imídasókínólínafleiður
DE50203093D1 (de)	2005-06-16	Losradlager
ATE319694T1 (de)	2006-03-15	Phenylalkyne
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE50209293D1 (de)	2007-03-08	Amidpolymermasse

Legal Events

Date	Code	Title	Description
2013-07-29	MM1K	Lapsed by not paying the annual fees